Mark Zaki

420 total citations
20 papers, 336 citations indexed

About

Mark Zaki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Mark Zaki has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Radiation. Recurrent topics in Mark Zaki's work include Advanced Radiotherapy Techniques (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Mark Zaki is often cited by papers focused on Advanced Radiotherapy Techniques (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Mark Zaki collaborates with scholars based in United States, United Kingdom and Egypt. Mark Zaki's co-authors include Ian English, Mohamed A. Elshaikh, Jared R. Robbins, Meredith Mahan, Thomas Buekers, Harold Kim, Ammar Sukari, M.M. Dominello, Misako Nagasaka and George H. Yoo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mark Zaki

19 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Zaki United States 7 144 143 126 52 46 20 336
Kenneth E. Najarian United States 9 101 0.7× 55 0.4× 162 1.3× 8 0.2× 42 0.9× 13 319
Sanne M Schreuder Netherlands 8 105 0.7× 16 0.1× 76 0.6× 34 0.7× 39 0.8× 13 380
Felipe Nasser Brazil 11 265 1.8× 29 0.2× 160 1.3× 25 0.5× 26 0.6× 55 414
Dong Erk Goo South Korea 13 180 1.3× 84 0.6× 207 1.6× 24 0.5× 13 0.3× 49 422
Breno Boueri Affonso Brazil 9 198 1.4× 30 0.2× 109 0.9× 23 0.4× 25 0.5× 45 330
Kalpana Yeddula United States 9 160 1.1× 84 0.6× 150 1.2× 24 0.5× 6 0.1× 15 394
John S. Cupp United States 6 83 0.6× 72 0.5× 94 0.7× 32 0.6× 8 0.2× 13 290
Hwan Hoon Chung South Korea 12 171 1.2× 39 0.3× 178 1.4× 27 0.5× 39 0.8× 54 388
Christoph Georg Radosa Germany 10 134 0.9× 30 0.2× 101 0.8× 61 1.2× 106 2.3× 31 350
Mangerira Uthappa United Kingdom 8 176 1.2× 21 0.1× 102 0.8× 15 0.3× 37 0.8× 19 360

Countries citing papers authored by Mark Zaki

Since Specialization
Citations

This map shows the geographic impact of Mark Zaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Zaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Zaki more than expected).

Fields of papers citing papers by Mark Zaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Zaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Zaki. The network helps show where Mark Zaki may publish in the future.

Co-authorship network of co-authors of Mark Zaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Zaki. A scholar is included among the top collaborators of Mark Zaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Zaki. Mark Zaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaki, Mark, Aya Osama, Eman Ahmed, et al.. (2025). A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients. International Journal of Molecular Sciences. 26(13). 5926–5926. 1 indexed citations
2.
Dykstra, Michael, Huiying Yin, Mark Zaki, et al.. (2024). Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium. Advances in Radiation Oncology. 9(11). 101629–101629. 1 indexed citations
3.
Dykstra, Michael, Huiying Yin, Patrick W. McLaughlin, et al.. (2024). Microboost dose escalation for localized prostate cancer within a statewide radiation oncology quality consortium.. Journal of Clinical Oncology. 42(4_suppl). 298–298. 1 indexed citations
5.
Zaki, Mark, et al.. (2020). Does Low Level Laser Therapy Improve Clinical Outcomes Related to Oral Mucositis in Patients Treated for Head and Neck Cancer?. International Journal of Radiation Oncology*Biology*Physics. 108(3). e812–e812. 1 indexed citations
6.
Burmeister, Jay, Kathryn Masi, Adrian Nalichowski, et al.. (2019). Imaging as Part of a Quality Assurance Program: Predictors of Interobserver Variability for Pretreatment Image Registration for Lung SBRT. Technology in Cancer Research & Treatment. 18. 3 indexed citations
7.
Bonomi, Robin, Mark Zaki, Michael Cronquist Christensen, et al.. (2018). Glioblastoma metastatic to the ovary, a very different Krukenberg tumor?. Practical Radiation Oncology. 8(6). 373–375. 3 indexed citations
8.
Nagasaka, Misako, et al.. (2017). Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck. The Laryngoscope. 127(10). 2260–2264. 6 indexed citations
9.
Zaki, Mark, M.M. Dominello, Gregory Dyson, et al.. (2016). Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 18(1). e21–e26. 5 indexed citations
10.
Zaki, Mark, M.M. Dominello, Robert Morris, & Stephen R. Miller. (2016). Factors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical Cancer. Cureus. 8(4). e558–e558. 5 indexed citations
11.
Nagasaka, Misako, Mark Zaki, Harold Kim, et al.. (2016). PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report. Journal for ImmunoTherapy of Cancer. 4(1). 83–83. 35 indexed citations
12.
Zaki, Mark, Yiqing Xu, Michael C. Joiner, Harold Kim, & M.M. Dominello. (2016). Cervical osteoradionecrosis following accelerated fractionation radiation therapy for laryngeal cancer. Practical Radiation Oncology. 6(6). 405–408. 2 indexed citations
13.
Dominello, M.M., Mark Zaki, Ahmad Hammoud, et al.. (2015). Ten-year trends in safe radiation therapy delivery and results of a radiation therapy quality assurance intervention. Practical Radiation Oncology. 5(6). e665–e671. 6 indexed citations
14.
Zaki, Mark, et al.. (2015). Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy. Cureus. 7(12). e432–e432. 8 indexed citations
15.
Shaikh, Talha, Mark Zaki, M.M. Dominello, et al.. (2015). Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer. Acta Oncologica. 55(3). 303–308. 10 indexed citations
16.
Dominello, M.M., et al.. (2014). Radiotherapy and radioembolization for liver metastases.. PubMed. 3(2). 104–13. 4 indexed citations
17.
Robbins, Jared R., et al.. (2013). Impact of Age-Adjusted Charlson Comorbidity score on outcomes for patients with early-stage endometrial cancer. Gynecologic Oncology. 131(3). 593–597. 65 indexed citations
18.
Zaki, Mark, et al.. (2012). Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement.. PubMed. 32(9). 4061–5. 5 indexed citations
19.
English, Ian, et al.. (1969). Percutaneous cannulation of the internal jugular vein. Thorax. 24(4). 496–497. 46 indexed citations
20.
English, Ian, et al.. (1969). Percutaneous catheterisation of the internal jugular vein. Anaesthesia. 24(4). 521–531. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026